Objective:The arrival of precision medicine plan brings new opportunities and challenges for patients undergoing precision diagnosis and treatment of malignant
Background:Coronary microembolization (CME) has been frequently seen in acute coronary syndromes and percutaneous coronary intervention.Small animal models are